Quick Answer
Korro Bio, Inc. reported Operating Income of -$121.86 million for fiscal year 2025.
Korro Bio, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$121.86M | -32.6% |
| 2024 | -$91.91M | -8.7% |
| 2023 | -$84.53M | -43.3% |
| 2022 | -$59.00M | +29.8% |
| 2021 | -$84.03M | -205.0% |
| 2020 | -$27.55M | -33.3% |
| 2019 | -$20.68M | -9.1% |
| 2018 | -$18.94M | -16.2% |
| 2017 | -$16.31M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$19.24M | +17.4% | +29.3% |
| June 30, 2025 | -$27.20M | -12.8% | -8.7% |
| March 31, 2025 | -$25.02M | -16.6% | -7.4% |
| September 30, 2024 | -$23.29M | -21.6% | +3.5% |
| June 30, 2024 | -$24.12M | -31.1% | -12.5% |
| March 31, 2024 | -$21.45M | -6.8% | -12.0% |
| September 30, 2023 | -$19.15M | +5.6% | -4.0% |
| June 30, 2023 | -$18.41M | +13.5% | +8.4% |
- Korro Bio, Inc. showed a decrease of -32.6% in Operating Income compared to the prior fiscal year.
- Over the 2017–2025 period, Korro Bio, Inc.’s operating income has declined by 647.3% (from -$16.31 million to -$121.86 million).
- The most recent figure is from Korro Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: